Verona Pharma Ltd - Company Profile
Powered by 
All the sales intelligence you need on Verona Pharma Ltd in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Verona Pharma Ltd fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Verona Pharma Ltd.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Verona Pharma Ltd patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| CA2948620C | Grant | CYSTIC FIBROSIS TREATMENT | A61K31/404; A61K31/443; A61K31/47; A61K31/519; A61K45/05; A61K45/06; A61P1/00; A61P11/00; A61P11/06; A61P11/12; A61P15/00; A61P43/00 | January 24, 2023 |
| KR1020220149669A | Application | 엔시펜트린 및 글리코피롤레이트를 포함하는 액상 약제학적 조성물 | A61K2300/00; A61K31/40; A61K31/513; A61K31/519; A61K47/02; A61K47/12; A61K47/14; A61K47/26; A61K9/0078; A61K9/10; A61P11/00 | November 08, 2022 |
| US11491155B2 | Grant | Salt of a pyrimido[6,1-A]isoquinolin-4-one compound | A61K2300/00; A61K31/185; A61K31/513; A61K31/519; A61K45/06; A61K9/0075; C07D471/04 | November 08, 2022 |
| ZA202102039B | Grant | PHARMACEUTICAL COMPOSITIONS COMPRISING RPL554 IN HFA-134A FOR ADMINISTRATION BY INHALATION | A61K31/4745; A61K31/519; A61K47/06; A61K9/008; A61K9/10; A61P11/08 | August 31, 2022 |
| US20220265549A1 | Application | PHARMACEUTICAL COMPOSITION COMPRISING ENSIFENTRINE | A61K31/519; A61K9/0075; A61K9/145; A61P11/00 | August 25, 2022 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer